BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
SOPHiA GENETICS & AstraZeneca Extend AI Collaboration for Breast Cancer Insights August 7, 2025 SOPHiA GENETICS and AstraZeneca deepen their partnership to apply multimodal AI for real-world breast cancer treatment optimization across Europe and North America.
Danaher, AstraZeneca Collaborate to Advance Diagnostic Innovation July 1, 2025 Danaher and AstraZeneca have partnered to fast-track AI-driven diagnostics and expand global access to precision medicine.
AstraZeneca Bets Big on AI Healthtech with INR 166 Cr Bengaluru Hub Expansion June 28, 2025 Global pharma giant AstraZeneca has announced a INR 166 Cr expansion of its global hub in Bengaluru. The new AI-driven facility will house 1,300 staff and create 400 new jobs, driving innovation in digital health, AI, and R&D. This marks the company's second major India investment within a year.
AstraZeneca & Qure.ai Achieve Major Milestone in AI-Driven Lung Cancer Screening May 2, 2025 The global screening effort helped detect 50,000 high-risk lung nodules, boosting early lung cancer detection in underserved regions.
AstraZeneca Study Highlights AI’s Potential in Lung Cancer Detection for Resource-Limited Settings April 2, 2025 AstraZeneca advocates for AI-driven lung cancer screening, presenting evidence on its positive impact in resource-constrained settings, aiming to improve early diagnosis and patient outcomes.
AstraZeneca Invests $2.5 Bn in Beijing for New R&D Center & Biotech Partnerships March 24, 2025 AstraZeneca commits $2.5 billion to establish a global strategic R&D centre, expand biotech collaborations, and boost manufacturing capabilities in Beijing, strengthening its global footprint.
AstraZeneca to Acquire EsoBiotec in $1 Bn Deal to Advance In Vivo Cell Therapies March 18, 2025 AstraZeneca announces the acquisition of EsoBiotec for up to $1 billion, strengthening its pipeline in biotechnology and expanding its portfolio of cutting-edge therapies.
AstraZeneca Announces $3.5 Bn Investment in US Expansion November 15, 2024 AstraZeneca announces $3.5 billion investment in US research and manufacturing, creating over 1,000 skilled jobs and strengthening its market footprint.
AstraZeneca India to Invest INR 250 Cr for Global Innovation & Tech Center in Tamil Nadu July 5, 2024 This initiative aims to enhance capabilities in enterprise platforms, artificial intelligence, machine learning, data science, and supply chain analytics for healthcare.
AstraZeneca Completes Acquisition of Fusion Pharma for $2.4 Bn June 7, 2024 This acquisition complements AstraZeneca’s leading oncology portfolio with the addition of the Fusion pipeline of RCs, including their most advanced programme, FPI-2265.
AstraZeneca Completes Equity Investment with Cellectis May 7, 2024 With this second investment, AstraZeneca now holds a total equity stake of approximately 44% in Cellectis.
AstraZeneca to Acquire Fusion Pharmaceuticals for $2.4 Bn, Strengthens Oncology Porfolio March 21, 2024 This acquisition marks another step in AstraZeneca's ongoing efforts to strengthen its lineup of innovative medicines.
